{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:20:08Z","timestamp":1761175208208,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ijid.2022.06.051","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T09:45:19Z","timestamp":1656841519000},"page":"143-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Is a single dose of ChAdOx1 nCoV\u201019 vaccine (AZD1222) enough for people with prior SARS\u2010CoV\u20102 infection or baseline seropositive status?"],"prefix":"10.1016","volume":"123","author":[{"given":"Vikas","family":"Deswal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Phogat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-7656","authenticated-orcid":false,"given":"Pooja","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushila","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvinder","family":"Soin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.06.051_bib0001","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMc2102051","article-title":"Antibody responses after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Bradley","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.06.051_bib0002","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.06.051_bib0003","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2022.06.051_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijid.2020.08.076","article-title":"Asymptomatic SARS coronavirus 2 infection: invisible yet invincible","volume":"100","author":"Nikolai","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.06.051_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijid.2021.05.034","article-title":"Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals","volume":"108","author":"Sasikala","year":"2021","journal-title":"Int J Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222003848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:09:06Z","timestamp":1761120546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222003848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":5,"alternative-id":["S1201971222003848"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.051","relation":{},"ISSN":["1201-9712"],"issn-type":[{"type":"print","value":"1201-9712"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is a single dose of ChAdOx1 nCoV\u201019 vaccine (AZD1222) enough for people with prior SARS\u2010CoV\u20102 infection or baseline seropositive status?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.06.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}